![Suzanne Fleming](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suzanne Fleming
Comptroller/Controller/Auditor chez BEAM THERAPEUTICS INC.
Postes actifs de Suzanne Fleming
Sociétés | Poste | Début | Fin |
---|---|---|---|
BEAM THERAPEUTICS INC. | Comptroller/Controller/Auditor | - | - |
Treasurer | 01/02/2019 | - |
Historique de carrière de Suzanne Fleming
Anciens postes connus de Suzanne Fleming
Sociétés | Poste | Début | Fin |
---|---|---|---|
EPIZYME, INC. | Comptroller/Controller/Auditor | 21/09/2017 | 31/01/2019 |
Directeur Financier/CFO | 21/09/2017 | 31/01/2019 | |
Treasurer | 21/09/2017 | 31/01/2019 | |
FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/10/2014 | 01/09/2017 |
AVEO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/11/2005 | 05/04/2011 |
Corporate Officer/Principal | 05/04/2011 | 01/01/2013 | |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Directeur Financier/CFO | - | 01/01/2005 |
Corporate Officer/Principal | 01/01/2003 | - | |
CytoTherapuetics, Inc. | Corporate Officer/Principal | 01/01/1995 | 01/01/1998 |
Oculon Corp
![]() Oculon Corp Pharmaceuticals: MajorHealth Technology Part of W World Corp., Oculon Corp is a pharmaceutical concern. Oculon was acquired by W World Corp. on April 13, 1995 for $4 million. | Corporate Officer/Principal | 01/01/1991 | 01/01/1995 |
Transkaryotic Therapies, Inc.
![]() Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formation de Suzanne Fleming
Stonehill College, Inc. | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Corporate Officer/Principal | 6 |
Director of Finance/CFO | 3 |
Comptroller/Controller/Auditor | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BEAM THERAPEUTICS INC. | Health Technology |
Entreprise privées | 7 |
---|---|
AVEO Pharmaceuticals, Inc.
![]() AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Transkaryotic Therapies, Inc.
![]() Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
CytoTherapuetics, Inc. | Finance |
Oculon Corp
![]() Oculon Corp Pharmaceuticals: MajorHealth Technology Part of W World Corp., Oculon Corp is a pharmaceutical concern. Oculon was acquired by W World Corp. on April 13, 1995 for $4 million. | Health Technology |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
Epizyme, Inc.
![]() Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Foundation Medicine, Inc.
![]() Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
- Bourse
- Insiders
- Suzanne Fleming
- Expérience